topSkip to main content

Menu, Secondary

Menu Trigger

Menu

National Institutes of Health

Biomedical research funded by the National Institutes of Health (NIH) and performed at research universities helps assure U.S. leadership in the life sciences revolution of the 21st Century. Putting NIH on a sustained pathway to restore its purchasing power after a decade worth of loss to inflation and budget cuts is critical to sustaining the extraordinary progress in the improvement of human health of the past decades. Investment in NIH will continue to create jobs and strengthen the workforce, improve the lives—and quality of life—of millions of current and future patients, and help assure continuing U.S. economic and national security.

Sustained investment in biotechnology and genomics is crucial to the development of novel therapies for diseases, including: cancer, Alzheimer's, autism, and diabetes. The NIH also responds rapidly to public health emergencies and in support of biodefense, such as in the case of Ebola, Zika, and influenza.

 

The Ad Hoc Group for Medical Research, of which AAU is a member, wrote to Congress recommending members appropriate $39.3 billion in FY 2019 for National Institutes of Health (NIH).
AAU urges Congress to provide at least $39.3 billion for the National Institutes of Health (NIH) in FY19.
AAU, APLU, and COGR submitted a letter to NIH in response to the agency’s Request for Comments on its Proposal to Update Data Management of Genomic Summary Results Under the NIH Genomic Data Sharing Policy.  The joint letter requests NIH clarify that the consent requirements detailed in the notice are limited to prospective collections and agrees that summary genomic data results should be provided through appropriate controlled access.
Over 60 organizations, including the Association of American Universities, wrote to Senate leaders opposing prohibitions or restrictions that would further impede the use of federal funding for fetal tissue or embryonic stem cell research.
AAU joined 108 national research organizations to oppose cuts to NIH funding and facilities and administrative (F&A) reimbursements in the Administration's FY18 budget.
Multiple coalitions urged members of the 115th Congress to pass a bipartisan budget agreement that increases the spending caps for both defense and non-defense discretionary programs.